Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Watson

Showing results (1371-1380 of 1,450) with videos related to

Pageof 145
Sort By:
Frontiers in Endocrinology|February 4, 2025
Associations between accurate measures of adiposity and fitness, blood proteins, and insulin sensitivity among South Asians and EuropeansPik Fang Kho, Laurel Stell, Shirin Jimenez, et al.
European Journal of Applied Physiology|April 18, 2013
Combined walking exercise and alkali therapy in patients with CKD4-5 regulates intramuscular free amino acid pools and ubiquitin E3 ligase expressionEmma L Watson, George C Kosmadakis, Alice C Smith, et al.
Nature Medicine|October 20, 2014
An in vivo model of human small intestine using pluripotent stem cellsCarey L Watson, Maxime M Mahe, Jorge Múnera, et al.
Critical Care Medicine|July 10, 2018
Methodologic Innovation in Creating Clinical Practice Guidelines: Insights From the 2018 Society of Critical Care Medicine Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption Guideline EffortJohn W Devlin, Yoanna Skrobik, Bram Rochwerg, et al.
Molecular Cancer Therapeutics|June 12, 2024
Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune ActivationLily L Nguyen, Zachary L Watson, Raquel Ortega, et al.
Molecular Cancer Therapeutics|May 7, 2024
Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune ActivationLily L Nguyen, Zachary L Watson, Raquel Ortega, et al.
Nature Cell Biology|June 19, 2026
Lysosome-derived methylated arginine is a signalling metabolite controlling the lipidomeSteven T Nguyen, Richard L Watson, Fangyuan Gao, et al.
Cancer Biology & Therapy|December 10, 2015
Poly (ADP) ribose polymerase inhibition: A potential treatment of malignant peripheral nerve sheath tumorChristine M Kivlin, Kelsey L Watson, Ghadah A Al Sannaa, et al.
Molecular Cancer Research : MCR|August 13, 2024
EHMT1/2 Inhibition Promotes Regression of Therapy-Resistant Ovarian Cancer Tumors in a CD8 T-cell-Dependent MannerLily L Nguyen, Zachary L Watson, Raquel Ortega, et al.
Iscience|August 23, 2019
Multi-Omic Approaches Identify Metabolic and Autophagy Regulators Important in Ovarian Cancer DisseminationLindsay J Wheeler, Zachary L Watson, Lubna Qamar, et al.
Pageof 145

Showing results (1371-1380 of 1,450) with videos related to

Sort By:
Pageof 145
Frontiers in Endocrinology|February 4, 2025
Associations between accurate measures of adiposity and fitness, blood proteins, and insulin sensitivity among South Asians and EuropeansPik Fang Kho, Laurel Stell, Shirin Jimenez, et al.
European Journal of Applied Physiology|April 18, 2013
Combined walking exercise and alkali therapy in patients with CKD4-5 regulates intramuscular free amino acid pools and ubiquitin E3 ligase expressionEmma L Watson, George C Kosmadakis, Alice C Smith, et al.
Nature Medicine|October 20, 2014
An in vivo model of human small intestine using pluripotent stem cellsCarey L Watson, Maxime M Mahe, Jorge Múnera, et al.
Critical Care Medicine|July 10, 2018
Methodologic Innovation in Creating Clinical Practice Guidelines: Insights From the 2018 Society of Critical Care Medicine Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption Guideline EffortJohn W Devlin, Yoanna Skrobik, Bram Rochwerg, et al.
Molecular Cancer Therapeutics|June 12, 2024
Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune ActivationLily L Nguyen, Zachary L Watson, Raquel Ortega, et al.
Molecular Cancer Therapeutics|May 7, 2024
Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune ActivationLily L Nguyen, Zachary L Watson, Raquel Ortega, et al.
Nature Cell Biology|June 19, 2026
Lysosome-derived methylated arginine is a signalling metabolite controlling the lipidomeSteven T Nguyen, Richard L Watson, Fangyuan Gao, et al.
Cancer Biology & Therapy|December 10, 2015
Poly (ADP) ribose polymerase inhibition: A potential treatment of malignant peripheral nerve sheath tumorChristine M Kivlin, Kelsey L Watson, Ghadah A Al Sannaa, et al.
Molecular Cancer Research : MCR|August 13, 2024
EHMT1/2 Inhibition Promotes Regression of Therapy-Resistant Ovarian Cancer Tumors in a CD8 T-cell-Dependent MannerLily L Nguyen, Zachary L Watson, Raquel Ortega, et al.
Iscience|August 23, 2019
Multi-Omic Approaches Identify Metabolic and Autophagy Regulators Important in Ovarian Cancer DisseminationLindsay J Wheeler, Zachary L Watson, Lubna Qamar, et al.
Pageof 145